Found 664 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query ec: 2.7.11.24

Total Genus Sequence Length pdb Title
116 349 8u8kA Co-crystal structure of phosphorylated erk2 in complex with erk1/2 inhibitor #8
119 352 8u8jA Co-crystal structure of phosphorylated erk2 in complex with erk1/2 inhibitor #16
98 344 8ygwA The crystal structure of mapk11 from biortus
103 357 8x5mA The crystal structure of jnk1 from biortus.
106 351 8x23A The crystal structure of mapk13 from biortus.
103 350 7w5oA Crystal structure of erk2 with an allosteric inhibitor
109 362 7opmA Phosphorylated erk2 in complex with orf45
105 347 7e73A Crystal structure of human erk2 mutant (y36h)
109 349 7e75A Crystal structure of human erk2 mutant (g37c)
93 350 8acmAAA Crystal structure of wt p38alpha
84 349 8acoAAA Crystal structure of wt p38alpha
113 340 7pusAAA Erk5 in complex with pyrrole carboxamide scaffold
114 355 7n8tA Crystal structure of amp-bound human jnk2
111 356 8efjA A structural study of selectivity mechanisms for jnk3 and p38 alpha with indazole scaffold probing compounds
95 356 8enjA Design, synthesis, biological evaluation, and x-ray crystallography of diarylpyrazole derivatives possessing terminal arylsulfonamide moieties as anti-proliferative agents targeting c-jun n-terminal kinase (jnk)
107 356 7yl1A Crystal structure of jnk3 in complex with a fragment molecule
112 355 8elcA Human jnk2 bound to covalent inhibitor yl2056
109 350 7z6iAAA Crystal structure of p38alpha c162s in complex with sb20358 and cas 2094667-81-7 (behind catalytic site; y35 in), p 21 21 21
103 349 7z9tAAA Crystal structure of p38alpha c162s in complex with atpgs and cas 2094667-81-7 (in catalytic site, y35 out), p 1 21 1
106 349 7pvuA Crystal structure of p38alpha c162s in complex with cas2094511-69-8, p 1 21 1
131 408 8h59A A fungal map kinase in complex with an inhibitor
109 346 7ugbA Crystal structure of rat erk2 complexed with docking peptide from isg20
112 351 7xc1A Crystal structure of erk2 with an allosteric inhibitor 3
113 350 7x4uA Crystal structure of erk2 with an allosteric inhibitor 2
111 355 7w5cA Crystal structure of mitogen activated protein kinase 4 (mpk4) from arabidopsis thaliana
107 346 8aoeA Specific covalent inhibitor(15) of erk2
112 346 8aoaA Covalent and non-covalent inhibitor of erk2 (two sites)
114 346 8aoiA Specific covalent inhibitor(19) of erk2
106 346 8ao6A Electrophilic inhibitor (7) of erk2
105 346 8aogA Non-specific covalent inhibitor(17) of erk2
113 347 8aojA Specific covalent inhibitor of erk2
107 346 8ao9A Specific covalent inhibitor(10) of erk2
107 347 8ao4A Specific covalent inhibitor (5) of erk2
110 342 8ao5A Specific covalent inhibitor (6) of erk2
110 339 8aobA Specific covalent inhibitor(12) of erk2
112 346 8aocA Specific covalent inhibitor of erk2
109 347 8ao3A Specific covalent inhibitor of erk2
107 346 8aohA Specific covalent inhibitor(18) of erk2
114 346 8ao7A Specific covalent inhibitor (8) of erk2
110 346 8aodA Specific covalent inhibitor(14) of erk2
106 345 8ao2A Specific covalent inhibitor (3) of erk2
108 346 8ao8A Specific covalent inhibitor(9) of erk2
106 346 8aofA Specific covalent inhibitor(16) of erk2
66 349 8a8mA Structure of the mapk p38alpha in complex with its activating map2k mkk6
102 356 7s1nA N-aromatic-substituted indazole derivatives as brain penetrant and orally bioavailable jnk3 inhibitors
110 346 7nqqA Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2
101 345 7nr9A Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2
113 346 7nr8A Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2
114 346 7nqwA Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2
109 347 7nr5A Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2